Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Bimatoprost + Timolol
Ganfort
Routinely available
SMC (906/13)
02/10/2013
Indication
For reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are sufficiently responsive to topical beta-blockers or prostaglandin analogues.
Therapeutic Area
Eye
Status Description
Routinely available in line with national guidance
Formulation
0.3mg/mL / 5mg/mL preservative-free single-dose eye-drops
Comments
October 2013 - Not included on the LJF because the NHS Lothian decision is that the medicine does not represent sufficient added benefit to other comparator medicines to treat the condition in question. July 2019 (as per LJF) - Routinely available in line with national guidance. Included in the LJF.
Link to Advice
Advice Published
07/10/2013
SMC Submission Type
Abbreviated
SMC Status
Restricted